AURAL de Strasbourg Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02176681
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

AURAL Clinique Saint-Anne de Strasbourg | Clinique Sainte Anne de Strasbourg | Clinique Sainte Anne, Strasbourg

Active Ingredients

Drugs in Phase 4 Trials (2)

insulin human (humulin) (1 trial)

vildagliptin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2